Archives

WindRose Health Investors Closes $2.6 Billion Fund VII To Accelerate Healthcare Investments

By Amit Chowdhry ● Dec 8, 2025

WindRose Health Investors has closed its seventh private equity fund at $2.6 billion, marking the largest fundraise in the firm’s history and nearly doubling the size of its prior vehicle. The New York-based healthcare investor reached its hard cap after a six-month fundraising period, attracting a global base of limited partners from pensions, insurers, financial institutions, foundations, funds of funds, and family offices.

Allworth Financial Expands In Boston With Acquisition Of $460 Million Firm FSA Wealth Management

By Amit Chowdhry ● Dec 8, 2025

Allworth Financial has announced its acquisition of FSA Wealth Management, a Needham, Massachusetts-based fiduciary advisory firm overseeing $460 million in assets under management. The transaction marks another step in Allworth’s strategy to expand its upmarket presence in regions where demand for sophisticated, integrated financial planning continues to grow. As part of the transition, FSA’s team will move to Allworth’s existing office in Waltham, Massachusetts.

Cresa Acquires CMPG To Expand Southern California Project Management Capabilities

By Amit Chowdhry ● Dec 8, 2025

Cresa has completed the acquisition of CMPG, a full-service project management firm based in Diamond Bar, marking the company’s third acquisition in the past forty-five days and further strengthening its occupier-focused service platform. The deal significantly expands Cresa’s project management capabilities across Southern California and deepens its regional footprint.

Causeway Therapeutics: Interview With CEO & Executive Chairman Declan Doogan About Developing microRNA-Based Therapies

By Amit Chowdhry ● Dec 8, 2025

Causeway Therapeutics is a clinical-stage biotech company developing novel microRNA-based therapies — principally their lead candidate, designed to repair tendon structure, relieve pain, and restore function in chronic tendon disease. Pulse 2.0 interviewed Causeway Therapeutics CEO and Executive Chairman Declan Doogan to gain a deeper understanding of the company.

Waverly Advisors Expands Alternatives Platform With Acquisition Of Select Promus Business Lines

By Amit Chowdhry ● Dec 8, 2025

Waverly Advisors has completed the acquisition of select business lines from Chicago-based Promus Holdings. This move significantly strengthens its presence in private equity, real estate, and multi-family office services. The transaction deepens Waverly’s offerings for high-net-worth and ultra-high-net-worth families while expanding its alternative investment strategies through the formation of a new subsidiary, Promus Capital Management.

Condé Nast: Vasanth Williams Named As Chief Product And Technology Officer

By Amit Chowdhry ● Dec 8, 2025

Condé Nast has appointed Vasanth Williams as its new chief product and technology officer, a hire that strengthens the company’s focus on digital innovation, audience engagement, and platform modernization. Williams will officially assume the role on December 8 and join the company’s executive leadership team.

Micruity: $20 Million Series A Raised For Advancing Retirement Income Solutions

By Amit Chowdhry ● Dec 8, 2025

Micruity has secured $20 million in Series A financing as the company accelerates its effort to modernize the data infrastructure behind retirement income solutions. The round was co-led by Rebalance Capital and Nationwide Ventures, with participation from J.P. Morgan Asset Management, Reinsurance Group of America, Guardian Life, Collab Capital, State Street Investment Management, and TIAA Ventures. Existing backers, including Allianz Life, Prudential Financial, Western & Southern Financial Group, Pacific Life, and SixThirty Ventures, also supported the new round. The latest investment brings Micruity’s total funding to $27 million.

Excelsior Sciences: $95 Million Raised To Advance Automated Chemistry And AI-Driven Drug Discovery

By Amit Chowdhry ● Dec 8, 2025

Excelsior Sciences has secured $95 million in new financing to expand its automated chemistry platform and accelerate the development and manufacturing of small molecules in the United States. The newly announced capital includes a $70 million Series A co-led by Deerfield Management, Khosla Ventures, and Sofinnova Partners, as well as a $25 million grant from New York’s Empire State Development. Additional participants include Cornucopian Capital, Eli Lilly and Company, Illinois Ventures, and MIT.

Unacast: $28 Million In Funding Raised To Advance Global Location Intelligence Platform

By Amit Chowdhry ● Dec 8, 2025

Unacast announced that it has secured $28 million in new financing from Vector Capital’s direct credit strategy, Vector Velocity, marking a significant step in the company’s expansion following its late-2023 merger with Gravy Analytics.

Crestline Adds $150 Million To Expand Partnership With Credent Wealth Management

By Amit Chowdhry ● Dec 8, 2025

Crestline Investors has expanded its partnership with Credent Wealth Management through an additional $150 million commitment aimed at supporting the firm’s continued expansion and acquisition efforts. Credent, founded in 2018 and headquartered in Indiana, operates as a fee-only Registered Investment Advisor and manages more than four billion dollars in assets.

Natalie Portman Becomes Strategic Partner As UNCAGED Innovations Accelerates Sustainable Luxury Push

By Amit Chowdhry ● Dec 8, 2025

UNCAGED Innovations has brought Academy Award-winning actor and long-time ethical consumerism advocate Natalie Portman on as a strategic partner, a move that strengthens the company’s efforts to scale its next-generation leather alternative across luxury and fashion markets.